GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Indies Pharma Jamaica Ltd (XJAM:INDIES) » Definitions » 5-Year EBITDA Growth Rate

Indies Pharma Jamaica (XJAM:INDIES) 5-Year EBITDA Growth Rate : 0.00% (As of . 20)


View and export this data going back to 2018. Start your Free Trial

What is Indies Pharma Jamaica 5-Year EBITDA Growth Rate?

Indies Pharma Jamaica's EBITDA per Share for the six months ended in . 20 was JMD0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Competitive Comparison of Indies Pharma Jamaica's 5-Year EBITDA Growth Rate

For the Medical Distribution subindustry, Indies Pharma Jamaica's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Indies Pharma Jamaica's 5-Year EBITDA Growth Rate Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Indies Pharma Jamaica's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Indies Pharma Jamaica's 5-Year EBITDA Growth Rate falls into.


;
;

Indies Pharma Jamaica 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Indies Pharma Jamaica  (XJAM:INDIES) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Indies Pharma Jamaica 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Indies Pharma Jamaica's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Indies Pharma Jamaica Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
1a Pimento Way, Freeport, Montego Bay, St. James, JAM
Indies Pharma Jamaica Ltd offers marketing and distribution services to its overseas pharmaceutical manufacturers. The company products include Anti-Hypertensive, Anti-Thrombolytic, Microcirculation Agent, Anti-Cholesterol, and others.

Indies Pharma Jamaica Headlines

No Headlines